Debbie Dillon
Papers
2
Total Citations
73
H-Index
2
About
Debbie Dillon is a leading researcher in the field of *in vitro* toxicology, with a primary focus on the health impacts of tobacco smoke. Her work is centered on developing and validating novel exposure systems that more accurately mimic real-world inhalation, moving beyond traditional, less representative testing methods. Her major contributions include pioneering the use of quartz crystal microbalances (QCMs) to precisely assess cigarette smoke particle deposition within the Vitrocell® exposure module, a critical step for standardizing dosimetry in whole-smoke experiments. This foundational work, published in 2013, has garnered 43 citations. Dillon further advanced the field by establishing a method for evaluating the genotoxicity of mainstream cigarette smoke using an aerosol-based bacterial reverse-mutation assay, a key paper cited 30 times. By tackling the significant challenge of testing complex gaseous mixtures and aerosols, her research has provided essential tools for the toxicological community, enabling more accurate risk assessment of tobacco products and contributing to the broader understanding of smoke-induced disease mechanisms.
Research Focus
Key Achievements
Top Papers
- 1
- 2